Cost-effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in France

Author:

Tremblay Gabriel,Cariou Clemence,Recher Christian,Dolph Mike,Brandt Patricia,Blanc Anne-Sandrine,Forsythe Anna

Funder

Novartis Pharmaceuticals Corporation

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Reference43 articles.

1. Visser, O., Trama, A., Maynadie, M., Stiller, C., Marcos-Gragera, R., De Angelis, R., Mallone, S., Tereanu, C., Allemani, C., Ricardi, U., Schouten, H.C.: Incidence, survival and prevalence of myeloid malignancies in Europe. Eur. J. Cancer 48(17), 3257–3266 (2012). https://doi.org/10.1016/j.ejca.2012.05.024

2. Khan, I., Altman, J.K., Licht, J.D.: New strategies in acute myeloid leukemia: redefining prognostic markers to guide therapy. Clin. Cancer Res. 18(19), 5163–5171 (2012). https://doi.org/10.1158/1078-0432.CCR-12-0313

3. Sant, M., Minicozzi, P., Mounier, M., Anderson, L.A., Brenner, H., Holleczek, B., Marcos-Gragera, R., Maynadie, M., Monnereau, A., Osca-Gelis, G., Visser, O., De Angelis, R.: Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Lancet Oncol. 15(9), 931–942 (2014). https://doi.org/10.1016/s1470-2045(14)70282-7

4. Maynadie, M., De Angelis, R., Marcos-Gragera, R., Visser, O., Allemani, C., Tereanu, C., Capocaccia, R., Giacomin, A., Lutz, J.M., Martos, C., Sankila, R., Johannesen, T.B., Simonetti, A., Sant, M., Group, H.W.: Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study. Haematologica 98(2), 230–238 (2013). https://doi.org/10.3324/haematol.2012.064014

5. Meyers, J., Yu, Y., Kaye, J.A., Davis, K.L.: Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs. Appl. Health Econ. Health Policy 11(3), 275–286 (2013). https://doi.org/10.1007/s40258-013-0032-2

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3